TAG ARCHIVES FOR research ethics roundup

22
May2015

In this week's Research Ethics Roundup, we explore how new approaches are being used to address longstanding questions, such as those raised by expanded access or compassionate use, and chart a course for the future of biomedical innovation.
Company Creates Bioethics Panel on Trial Drugs: In an effort to address concerns related to compassionate use requests, Johnson and Johnson announced last week that they have appointed bioethicist Arthur L. Caplan, PhD, to "to create a panel that will make decisions about patients' requests for potentially lifesaving medicine."
Read more

8
May2015

From the introduction of apps designed to facilitate research to the growth of personalized medicine, this week's Research Ethics Roundup highlights questions raised by the use of innovative technologies in research. Read on and share your thoughts in the comments.

Chimpanzees Granted Petition to Hear 'Legal Persons' Status in Court: On April 20, in response to a petition from the Nonhuman Rights Project (NhRP), a New York state judge granted a writ of habeas corpus to two research chimpanzees at Stony Brook University. The decision was quickly amended to remove the term 'writ of habeas corpus,' but at a hearing in May representatives [...] Read more

24
Apr2015

In this week’s Research Ethics Roundup, we explore how shifting conceptions of research—from the growing demand for the sharing of clinical trial data to a renewed emphasis on statistical power in animal research—are challenging current thinking. Read on and share your thoughts on these pieces and other research ethics and oversight news in the comments.
Is the Placebo Effect in Some People’s Genes?:  A recent study published in Trends in Molecular Biology found that an individual’s response to a placebo may be affected by his or her genetics. This article from Reuters provides an [...] Read more

10
Apr2015

In this week's Research Ethics Roundup, we explore some of the ethical and practical questions posed by new innovations in the research enterprise, as well as some age old concerns, such as the recruitment of subjects for clinical trials. Read on:

FDA, Sponsors Look to Expand Patient Input to Clinical Trials: The involvement of patient groups in the design of clinical trials is becoming increasingly common. In this article for Applied Clinical Trials, Jill Wechsler reports on this shift, as well as the Food and Drug Administration's efforts to foster patient-focused drug development.

Read more

13
Mar2015

Technology takes center stage in this week's Research Ethics Roundup. On Monday, Apple introduced a new open-source framework that could have significant implications for the research enterprise, while, on the same day, the Food and Drug Administration (FDA) released draft guidance aimed at clarifying the use of electronic processes to obtain informed consent.

Apple's ResearchKit Is a New Way to Do Medical Research: On Monday, Apple announced ResearchKit, an "open-source framework that lets medical researchers create diagnostic apps that tap into the screens and accelerometers on the iPhone." This article from Wired discusses the announcement and how the use of the framework could revolutionize research.Read more